← FDA Warning Letters
Re-Gen Active Lab, Inc.
FDA Warning Letter · 2022-06-28 · Office of Biological Products Operations – Division 2
Letter
- Company
- Re-Gen Active Lab, Inc.
- Posted Date
- 2022-06-28
- Letter Issue Date
- 2022-05-27
- Issuing Office
- Office of Biological Products Operations – Division 2
Subject
Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)
Source
- Authoritative
- FDA Warning Letters
- Machine
- JSON-LD · Markdown